Otitis media with effusion: The role of Helicobacter Pylori in its pathogenesis

Laith Khasawneh1, Adi H Khassawneh2, Khalid A Kheirallah2

  • 1Department of Surgery, Faculty of Medicine, The Hashemite University, Zarqa, Jordan.

Abstract

Insights

Helicobacter Pylori was not detected in middle ear effusions of patients with Otitis Media with Effusion (OME). This suggests H. Pylori does not contribute to OME development, despite reflux being a factor in some cases.

Area of Science:

  • Otolaryngology
  • Microbiology
  • Molecular Biology

Background:

  • Otitis Media with Effusion (OME) is a common middle ear disease with multifactorial causes including infections and anatomical changes.
  • Potential roles of various pathogens in OME pathogenesis are continually investigated.

Purpose of the Study:

  • To investigate the presence of Helicobacter Pylori in middle ear effusions of OME patients using RT-PCR.
  • To compare findings with existing literature on OME etiology.

Main Methods:

  • A cohort of 132 consecutive OME patients were enrolled between October 2007 and February 2009.
  • Middle ear fluid samples were analyzed for Helicobacter Pylori DNA via RT-PCR.

Main Results:

  • Of 167 adequate samples analyzed, none showed detectable Helicobacter Pylori.
  • The study demonstrated a complete absence of H. Pylori in the endo-tympanic exudate of OME patients.

Conclusions:

  • Helicobacter Pylori does not appear to be involved in the pathophysiology of Otitis Media with Effusion.
  • While reflux is associated with OME in some cases, H. Pylori is not a contributing factor found in middle ear fluid.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
890
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
735
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
868
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
863
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
471
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.4K